Tiziana Life Sciences reported total assets of $11.49M and total liabilities of $11.44M for the quarter ended Dec 2025, down 5.7% year over year. This balance sheet covers 14 quarters of results from Dec 2017 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Dec2017 | Dec2018 | Dec2019 | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Jun2023 | Dec2023 | Jun2024 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash & EquivalentsCash & Equiv. | 0.06M | 5.30M | 0.20M | 65.82M | 53.28M | 42.19M | 26.54M | 18.12M | 6.60M | 1.18M | 1.13M | 3.72M | 7.25M | 4.01M |
| Cash & Current Investments | 0.06M | 5.30M | 0.20M | 65.82M | 53.28M | 42.19M | 26.54M | 18.12M | 6.60M | 1.18M | 1.13M | 3.72M | 7.25M | 4.01M |
| Receivables - NetNet Receivables | 2.38M | 1.07M | 0.17M | 0.79M | 1.30M | 0.30M | ||||||||
| Receivables - OtherOther Receivables | 0.11M | 0.25M | 0.13M | 0.37M | 0.47M | 0.46M | 0.61M | 4.55M | 3.65M | 4.02M | 2.85M | 0.18M | 4.88M | 0.56M |
| Receivables | 2.49M | 1.32M | 0.30M | 1.15M | 1.76M | 4.85M | ||||||||
| Prepaid Assets | 0.04M | 0.04M | 0.03M | 0.38M | 1.19M | 0.17M | 0.22M | 0.15M | 0.46M | |||||
| Current Assets | 2.45M | 6.91M | 1.51M | 70.18M | 57.15M | 48.68M | 32.32M | 24.28M | 15.18M | 7.34M | 7.75M | 7.51M | 12.72M | 8.55M |
| Non-Current Assets | ||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.02M | 0.01M | 0.01M | 0.00M | 0.02M | 0.02M | 0.01M | 0.02M | 0.01M | 0.01M | 0.02M | 0.02M | 0.03M | |
| Long-Term Investments | 2.68M | 1.81M | 1.89M | 4.55M | 2.97M | 3.59M | 3.73M | 2.44M | ||||||
| Intangibles | 0.43M | 0.12M | 0.13M | 0.13M | 0.12M | 0.37M | 0.28M | 0.17M | 0.47M | |||||
| Goodwill & Intangibles | 0.43M | 0.12M | 0.13M | 0.13M | 0.12M | 0.37M | 0.28M | 0.17M | 0.47M | |||||
| Other Non-Current Assets | 0.29M | |||||||||||||
| Non-Current Assets | 0.02M | 0.01M | 0.87M | 0.48M | 0.72M | 0.15M | 2.81M | 2.20M | 2.24M | 4.85M | 3.21M | 3.78M | 3.88M | 2.94M |
| Assets | 2.47M | 6.92M | 2.38M | 70.66M | 57.87M | 48.83M | 35.13M | 26.48M | 17.42M | 12.18M | 10.96M | 11.28M | 16.60M | 11.50M |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payables | 4.75M | 5.95M | 6.40M | 5.59M | 6.85M | 6.18M | 5.27M | 6.53M | 3.76M | 6.39M | 8.92M | 7.23M | 7.18M | 10.46M |
| Payables | 4.75M | 5.95M | 6.40M | 5.59M | 6.85M | 6.18M | 5.27M | 6.53M | 3.76M | 6.39M | 8.92M | 7.23M | 7.18M | 10.46M |
| Accumulated Expenses | 2.50M | 0.90M | 0.85M | 1.57M | 0.82M | 2.25M | 1.44M | 1.65M | 1.70M | |||||
| Other Accumulated Expenses | 0.45M | 0.59M | 1.72M | 1.58M | 1.36M | 5.27M | 6.53M | 3.76M | 6.39M | 8.92M | 0.22M | |||
| Current Taxes | 0.10M | |||||||||||||
| Current Deferred Revenue | 0.53M | |||||||||||||
| Total Current Liabilities | 4.75M | 6.40M | 7.35M | 7.98M | 7.55M | 6.66M | 6.54M | 7.35M | 11.21M | |||||
| Non-Current Liabilities | ||||||||||||||
| Capital Leases | 0.14M | 0.15M | 0.06M | |||||||||||
| Operating Leases | 0.54M | 0.29M | 0.23M | 0.24M | 0.17M | 0.11M | 0.14M | 0.11M | 0.11M | 0.23M | ||||
| Other Non-Current Liabilities | 0.08M | 0.09M | 0.08M | 0.01M | 0.01M | 0.37M | 0.01M | 0.25M | 0.01M | 0.01M | 0.01M | 0.00M | ||
| Total Non-Current Liabilities | -67.33M | 8.19M | 74.81M | 7.54M | 43.40M | 6.54M | 26.03M | 6.40M | 15.68M | 7.34M | 22.22M | 11.45M | ||
| Total Liabilities | 4.75M | -68.85M | -67.25M | 8.27M | 74.89M | 7.55M | 43.41M | 6.91M | 26.04M | 6.65M | 15.69M | 7.35M | 22.23M | 11.44M |
| Shareholder's Equity | ||||||||||||||
| Common Equity | -2.28M | 75.77M | 69.63M | 62.39M | -17.03M | 41.28M | -8.28M | 19.57M | -8.62M | 5.54M | -4.73M | 3.94M | -5.63M | 0.05M |
| Liabilities and Shareholders Equity | 2.47M | 6.92M | 2.38M | 70.66M | 57.87M | 48.83M | 35.13M | 26.48M | 17.42M | 12.18M | 10.96M | 11.28M | 16.60M | 11.50M |
| Treasury Shares | -0.81M | 1.32M | -1.57M | 1.57M | -1.57M | 0.05M | ||||||||
| Retained Earnings | -42.61M | -50.72M | -60.04M | -84.65M | -101.67M | -108.06M | -112.57M | -116.26M | -124.88M | -133.68M | -138.27M | -144.83M | -150.46M | -163.11M |
| Preferred Shares | 13.50M |
Pull Tiziana Life Sciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=TLSA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "TLSA", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=TLSA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();